Secondary amyloidosis complication of Crohn disease treated with infliximab / 영남의대학술지
Yeungnam University Journal of Medicine
;
: 102-105, 2015.
Article
in Korean
| WPRIM
| ID: wpr-213788
ABSTRACT
Secondary systemic (AA) amyloidosis is a severe complication of progressed Crohn disease (CD) characterized by the deposition of amyloid A in body organs and tissues. Various therapeutic approaches have been recommended, however there is still no effective treatment. Recently, several case reports have demonstrated the effects of anti-tumor necrosis factor-alpha therapy in patients with AA amyloidosis associated with CD. We report on a 35-year-old female patient with CD complicated by AA amyloidosis in the gastrointestinal tract and renal involvement, who was treated with infliximab. The infliximab therapy improved the gastrointestinal symptoms and decreased the serum creatinine.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Crohn Disease
/
Creatinine
/
Gastrointestinal Tract
/
Infliximab
/
Amyloid
/
Amyloidosis
/
Necrosis
Limits:
Adult
/
Female
/
Humans
Language:
Korean
Journal:
Yeungnam University Journal of Medicine
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS